Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA chief scientist wants BPA review

This article was originally published in The Tan Sheet

Executive Summary

At the request of newly appointed FDA Chief Scientist Frank M. Torti, a new Science Board subcommittee will hold a public meeting on the safety of bisphenol-A in plastics, review an FDA Task Force report on BPA and deliver its findings to the Science Board's annual meeting in the fall, according to a June 6 FDA release. The Task Force will make recommendations to Commissioner Andrew von Eschenbach following its review. Michigan Democrats John Dingell, chairman of the House Energy and Commerce Committee, and Oversight and Investigations Subcommittee Chairman Bart Stupak in April asked FDA to reconsider BPA's safety in infant products (1"The Tan Sheet" April 12, 2008, In Brief)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101743

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel